These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 16909012)
1. Plasma homocysteine and risk of coexisting silent brain infarction in Alzheimer's disease. Matsui T; Nemoto M; Maruyama M; Yuzuriha T; Yao H; Tanji H; Ootsuki M; Tomita N; Matsushita S; Higuchi S; Yoshida Y; Seki T; Iwasaki K; Furukawa K; Arai H Neurodegener Dis; 2005; 2(6):299-304. PubMed ID: 16909012 [TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251 [TBL] [Abstract][Full Text] [Related]
3. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. Sundelöf J; Sundström J; Hansson O; Eriksdotter-Jönhagen M; Giedraitis V; Larsson A; Degerman-Gunnarsson M; Ingelsson M; Minthon L; Blennow K; Kilander L; Basun H; Lannfelt L J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147 [TBL] [Abstract][Full Text] [Related]
4. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related]
5. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615 [TBL] [Abstract][Full Text] [Related]
6. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele. Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606 [TBL] [Abstract][Full Text] [Related]
7. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Irizarry MC; Gurol ME; Raju S; Diaz-Arrastia R; Locascio JJ; Tennis M; Hyman BT; Growdon JH; Greenberg SM; Bottiglieri T Neurology; 2005 Nov; 65(9):1402-8. PubMed ID: 16275827 [TBL] [Abstract][Full Text] [Related]
8. [Cerebrospinal fluid protein tau levels in the differential diagnosis of Alzheimer's disease]. Schonknecht P; Pantel J; Werle E; Hartmann T; Essig M; Baudendistel K; Beyreuther K; Schroder J Fortschr Neurol Psychiatr; 2000 Oct; 68(10):439-46. PubMed ID: 11103680 [TBL] [Abstract][Full Text] [Related]
9. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Motter R; Vigo-Pelfrey C; Kholodenko D; Barbour R; Johnson-Wood K; Galasko D; Chang L; Miller B; Clark C; Green R Ann Neurol; 1995 Oct; 38(4):643-8. PubMed ID: 7574461 [TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. Mizrahi EH; Bowirrat A; Jacobsen DW; Korczyn AD; Traore F; Petot GJ; Lerner AJ; Debanne SM; Adunsky A; Dibello PM; Friedland RP J Neurol Sci; 2004 Dec; 227(1):109-13. PubMed ID: 15546600 [TBL] [Abstract][Full Text] [Related]
11. Biomarker profiles and their relation to clinical variables in mild cognitive impairment. Schoonenboom SN; Visser PJ; Mulder C; Lindeboom J; Van Elk EJ; Van Kamp GJ; Scheltens PH Neurocase; 2005 Feb; 11(1):8-13. PubMed ID: 15804919 [TBL] [Abstract][Full Text] [Related]
12. Behavioural and psychological symptoms of Alzheimer type dementia are not correlated with plasma homocysteine concentration. Tabet N; Rafi H; Weaving G; Lyons B; Iversen SA Dement Geriatr Cogn Disord; 2006; 22(5-6):432-8. PubMed ID: 16983185 [TBL] [Abstract][Full Text] [Related]
13. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients. Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793 [TBL] [Abstract][Full Text] [Related]
14. Elevated plasma homocysteine is associated with increased brain atrophy rates in older subjects with mild hypertension. Narayan SK; Firbank MJ; Saxby BK; Stansby G; Hansrani M; O'Brien JT; Ford GA Dement Geriatr Cogn Disord; 2011; 31(5):341-8. PubMed ID: 21597295 [TBL] [Abstract][Full Text] [Related]
15. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology. Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582 [TBL] [Abstract][Full Text] [Related]